1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Trifluridine–tipiracil for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after 2 or more therapies

Technology appraisal guidance [TA669] Published: 27 January 2021

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

History

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 156 KB 27 January 2021  

Declaration of interests

  • Register of interests PDF 152 KB 27 January 2021  

Final draft guidance

  • Final draft guidance  
  • Final appraisal document PDF 236 KB 11 December 2020  
  • Committee papers PDF 1.36 MB 11 December 2020  
  • Public committee slides PDF 380 KB 11 December 2020  

Draft guidance

  • Draft guidance  
  • Committee papers PDF 4.46 MB 30 December 2019  
  • Public committee slides PDF 806 KB 30 December 2019  
  • Appraisal consultation document (PDF version) PDF 301 KB 30 December 2019  
  • Appraisal consultation document (online commenting)  

Invitation to participate

  • Final stakeholder list PDF 212 KB 05 April 2019  
  • Final scope PDF 176 KB 05 April 2019  
  • Draft scope and provisional stakeholder list comments table (post-referral) PDF 154 KB 05 April 2019  
  • Equality Impact Assessment (Guidance development) PDF 122 KB 05 April 2019  

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

  • Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators  
  • Draft scope post referral PDF 318 KB 06 February 2019  
  • Draft matrix post referral PDF 300 KB 06 February 2019